Chain Drug Review - Evoclin approved
November 22, 2004 -- Connetics Corp.'s Evoclin has been approved for treating acne. The Palo Alto, Calif.-based company is now entering the dermatology market...
Pediatric News - Atrovent HFA Inhalation Aerosol, Evoclin Foam
January 1, 2005 -- Atrovent HFA Inhalation Aerosol (ipratropium bromide HFA, Boehringer Ingelheim Pharmaceuticals) The Food and Drug Administration approved...
Business Wire - Connetics Presents 11 Scientific Posters at American Academy of Dermatology's 63rd Annual Meeting; Studies Feature New Data on Velac and Evoclin
February 17, 2005 -- PALO ALTO, Calif. -- Connetics Corporation (Nasdaq:CNCT), a specialty pharmaceutical company that develops and commercializes dermatology products,...
Business Wire - Connetics Enters Acne Market with Commercial Launch of Evoclin; Clindamycin in Patient-Preferred VersaFoam Formulation Now Available
December 13, 2004 -- PALO ALTO, Calif. -- Connetics Corporation (Nasdaq:CNCT), a specialty pharmaceutical company that develops and commercializes dermatology products,...
Business Wire - Connetics Second Quarter Revenues Increase 19 Percent; OLUX, Soriatane and Evoclin Achieve All-Time Quarterly Prescription Highs; Company Increases Full-Year...
August 2, 2005 -- PALO ALTO, Calif. -- Connetics Corporation (NASDAQ:CNCT), a specialty pharmaceutical company that develops and commercializes dermatology products,...
Business Wire - Stiefel Laboratories Will Enter Into Private Equity Minority Investment Agreement with The Blackstone Group
August 9, 2007 -- Partnering with The Blackstone Group Provides Robust Platform for Continued Growth CORAL GABLES, Fla. -- Stiefel Laboratories, Inc. announced today...
Business Wire - Stiefel Laboratories Receives FDA Approval of Olux-E Foam, 0.05% for Treatment of Psoriasis and Eczema
January 23, 2007 -- -- Company's Second Product in Emollient-Based Foam Delivery Vehicle -- CORAL GABLES, Fla. -- Stiefel Laboratories, Inc., the world's largest...
Business Wire - Connetics Announces Results of Special Stockholders Meeting
December 20, 2006 -- PALO ALTO, Calif. -- Connetics Corporation (Nasdaq:CNCT), a specialty pharmaceutical company that develops and commercializes dermatology products,...
Business Wire - Connetics Announces Expiration of Hart-Scott-Rodino Waiting Period
December 15, 2006 -- PALO ALTO, Calif. -- Connetics Corporation (Nasdaq:CNCT), a specialty pharmaceutical company that develops and commercializes dermatology products,...
Business Wire - Connetics Announces Special Meeting of Stockholders to Approve Merger With Stiefel Laboratories, Inc
November 17, 2006 -- PALO ALTO, Calif. -- Connetics Corporation (Nasdaq:CNCT), a specialty pharmaceutical company that develops and commercializes dermatology products,...
